热景生物(688068)每日收评(04-07)

Core Viewpoint - The stock of Rejing Bio (688068) shows a strong overall score of 67.13, indicating a robust performance in the market [1]. Price Analysis - The current main cost for the stock is 96.00 CNY, with a 5-day main cost of 104.18 CNY, a 20-day main cost of 91.30 CNY, and a 60-day main cost of 75.28 CNY [1]. - The stock has experienced 2 instances of hitting the upper limit and no instances of hitting the lower limit in the past year [1]. Technical Analysis - The short-term resistance level is at 111.10 CNY, while the short-term support level is also at 111.10 CNY [2]. - The market trend is currently unclear, with expectations for main funds to choose a direction [2][3]. - A gap in the K-line indicates potential upward or downward movement, with significant volume suggesting active participation if upward [2][3]. Fund Flow Data - As of April 7, 2025, the net inflow of main funds is 699.68 million CNY, accounting for 2% of the total transaction volume [2][3]. - The net inflow from large orders is 569.40 million CNY, while the net inflow from small orders is 362.16 million CNY [2][3]. Financial Data - The latest financial report shows an earnings per share of -0.44 CNY and an operating profit of -0.38 billion CNY [4]. - The sales gross margin stands at 56.893%, with a net profit of -42,681,396.61 CNY [4]. Related Industry/Concept Sectors - The stock is associated with sectors such as medical devices (-13.05%), food safety (-11.20%), national security (-14.02%), and in vitro diagnostics (-12.32%) [4].